drugset / Trial / NCT00030888

UCN-01 in Treating Patients With Advanced or Metastatic Kidney Cancer

NCT00030888

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of UCN-01 in treating patients who have unresectable stage III or stage IV kidney cancer.

Timeline

Start
2002-12
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject UCN-01 Small molecule Intravenous

Indications